Status:
NOT_YET_RECRUITING
Evaluating the Impact of Psychotherapeutic Advertising Claims on Cannabis Purchasing
Lead Sponsor:
Trustees of Dartmouth College
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Anxiety
Depression
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
In the U.S., legal cannabis is frequently advertised as an effective treatment for mental health problems such as anxiety and depression-particularly online. States that have legalized cannabis have n...
Detailed Description
The U.S. legal cannabis industry increasingly uses psychotherapeutic advertising claims (PACs) on its websites to promote products that contain Δ⁹-tetrahydrocannabinol (THC; the primary intoxicant in ...
Eligibility Criteria
Inclusion
- Age 21 years or older
- Current residence in the United States
- Cannabis use on 1-100 days in the past year
- Current symptoms of mild to severe depression and/or generalized anxiety disorder, assessed by PHQ-8 (score ≥ 5) and GAD-7 (score ≥ 5)
Exclusion
- Under 21 years of age
- Not currently residing in the United States
Key Trial Info
Start Date :
January 30 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT07216911
Start Date
January 30 2026
End Date
July 31 2026
Last Update
October 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Technology and Behavioral Health (CTBH), Geisel School of Medicine at Dartmouth College
Lebanon, New Hampshire, United States, 03766